ProMetic receives clearance to start trial of PBI-4050 in metabolic-syndrome-associated diabetes Jan. 29, 2015 No Comments
Tekmira authorized to start phase I trial of RNAi therapeutic for HBV infection Dec. 29, 2014 No Comments
Health Canada clears Immunovaccine to conduct phase II trial of DPX-Survivac Nov. 20, 2014 No Comments